Validation of a Combined Biomarker Including FGF-23, Erythropoietin, and Klotho for Development AKI and Clinical Outcomes in Patients in the Intensive Care Unit (ICU)

Michea, L.; Toro, L.; Rojas V.; Ponce, D; Irarrázabal C.; Fischer D.; Romero C.; Guerrero, J

Más información

Título según WOS: Validation of a Combined Biomarker Including FGF-23, Erythropoietin, and Klotho for Development AKI and Clinical Outcomes in Patients in the Intensive Care Unit (ICU)
Volumen: 35
Número: 10
Fecha de publicación: 2024
Idioma: English
DOI:

10.1681/ASN.2024pje2ewrf

Notas: ISI